跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71,130 条关于
“large-cell neuroendocrine carcinoma”
全部
71,130
临床试验
50,845
药物
4,577
机构
184
资讯
15,524
去年
Combination Therapy Achieves 15-Month Progression-Free Survival in Advanced Large-Cell Neuroendocrine Lung Carcinoma
2年前
ABD-147 and PT217 Receive FDA Orphan Drug Designations for Neuroendocrine Carcinoma Treatment
去年
DLL3-Targeted CAR-T Therapy LB2102 Shows Promise in Relapsed/Refractory Small Cell Lung Cancer
去年
Abdera Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
3个月前
FDA Draft Guidance Aims to Accelerate Cell and Gene Therapy Development
去年
Leads Biolabs' LBL-024 Receives FDA Orphan Drug Designation for Neuroendocrine Cancer
29天前
DLL3 Targeted Therapies Market Poised to Exceed $2 Billion by 2030 as Combination Strategies Accelerate
2年前
FDA Grants Fast Track Designation to Phanes Therapeutics' PT217 for Advanced Small Cell Lung Cancer
去年
BI 764532 T-Cell Engager Shows Promise in DLL3-Positive Neuroendocrine Carcinomas with 29% Response Rate
去年
Abdera Therapeutics Reports Promising Early Data for DLL3-Targeted Radiopharmaceutical ABD-147 in Small Cell Lung Cancer
第 1 页，共 1553 页
上一页
下一页
